A comparative study related to the preparation of poly(2-hydroxyethyl methacrylate) (pHEMA) through radical polymerization process in the presence of three different protective colloid substances, respectively poly(vinyl alcohol) (PVA), β-cyclodextrin, or poly(aspartic acid) (PAS), is presented. The dependence of the thermal behavior of the polymers as well as their morphological aspect, on the protective colloids used in synthesis was evidenced by polymers characterization. It is also demonstrated that the swelling capacity is dependent on the protective colloid variant present during the pHEMA preparation. This behavior induces as well interdependence on the ability to load bioactive compounds onto the polymeric matrices. The distribution of the indomethacin (INN), as model drug, into the pHEMA network was put into evidence by near infrared chemical imaging (NIR-CI), a non-destructive technique and with its correspondingly statistical analysis.
Introduction
Methacrylic polymers and copolymers are widely used for various medical and pharmaceutical applications. Among them poly(2-(hydroxyethyl) methacrylate) (pHE-MA) is favored for preparing intraocular lenses, and microbeads for vascular embolization, immobilization of cells, enzymes or pharmacological drugs. The hydroxyethyl pending groups of the polymer ensure high hydrophilicity, good biocompatibility and the possibility to prepare pHEMA in the form of a hydrogel [1, 2] .
As it is well known, the heterogeneous free radical polymerization process involves the relative solubilization of the hydrophobic monomers in water for example by an oil-in-water emulsifier, followed by the initiation reaction with either a water insoluble initiator or an oilsoluble initiator [3] . During polymerization an extremely large oil-water interfacial area is generated as the particle nuclei form, which is growing in size with the progress of the process. Effective stabilizers such as ionic and/or non-ionic surfactants and protective colloid, which can be physically adsorbed or chemically incorporated onto the particle surface, are required to prevent the interactive latex particles from coagulation. Thus, satisfactory colloidal stability is achieved by the electrostatic stabilization mechanism [4] , the steric stabilization mechanism [5] or both. The formation of stable colloidal particles during polymerization of 2-hydroxyethyl methacrylate, as water-soluble monomer but insoluble homopolymer, requires a proper choice of initiator and/or surfactant. Thus, stable latex products were produced from 2-hydroxyethyl methacrylate, only if hydrophobic initiators (e.g. AIBN or benzoyl peroxide) in combination with alkyl sulfate with the alkyl chain length greater than 10 or surface-active initiators (e.g. 2, 20-azobis(N-20-methylpropanoyl-2-amino-alkyl-1)-sulfonate) with the alkyl chain length greater than eight were used [6] .
The preparation of poly(2-hydroxyethyl methacrylate) latex with adequately high solid content is not easy at all compared to the hydrogel preparation, since the monomer exhibits an extremely high aqueous solubility and the latex faces coagulation easily [7] . The polymerization of 2-hydroxyethyl methacrylate (HEMA), using a series of initiators (2,2'-azobisisbutyronitrile, 2,2'-azobis-(2-amidinopropane) dihydrochloride, 4,4'-azobis(4-cyanopentanoic acid) (ACPA), 1,1'-azobis(cyclohexane carbonitrile)) and using either sodium lauryl sulfate (SLS) as emulsifier or a mixture of SLS and poly(vinyl pyrrolidone) (PVP) as tensioactive system, has been already reported [8] .
The goal of our investigation was to study the pHEMA characteristics, especially from the viewpoint of its capacity of coupling bioactive substances, after preparing the polymer through radical dispersion polymerization in the presence of ACPA as initiator and using classic tensioactive-sodium lauryl sulfate (SLS)-in tandem with one of the following protective colloids: poly(vinyl alcohol) (PVA), or β-cyclodextrine (CD) or poly(aspartic acid) (PAS).
It is known for the beneficial effect of PVA as protective colloid, which limits the flocculation of the interactive particles, restrains the coalescence between monomer droplets and the polymer particles, and also, improves generally the performance of the latex characteristics.
CD was also tested in the polymerization processes of the extremely hydrophobic dodecyl methacrylate or octadecyl methacrylate to study the role of β cyclodextrine in the nucleation and growth of particle nuclei and transport of those monomer molecules from monomer droplets to the growing latex particles, as far as CD forms inclusion with the guest species, and thus, increases the water solubility of the hydrophobic compounds [9] [10] [11] [12] .
PAS belonging to the family of synthetic polypeptides is a typical biocompatible, biodegradable water-soluble polymer with dispersing activity, and it can be used as dispersant, antiscalant, or superabsorber, for home detergents, water treatment chemicals, and oil field treatment additives, for a variety of organic and inorganic solids and scales dispersal, and in medicines, cosmetics, and food. It is considered to be a sustainable, environmentally compatible chemical product and its biodegradability makes it particularly valuable from the viewpoint of environmental acceptability and waste disposal [13, 14] . Its use as protective colloid will induce the increase of the absorbent character as well as biocompatibility and biodegradability for the system.
The thermal stability of the synthesized polymers was evaluated and the polymer network morphology was examined by SEM investigations. The new polymeric structures were also tested from the viewpoint of their capacity to be loaded with a bioactive compound. Thus, the swelling degree of the pHEMA was determined related to the pH and at two temperature values (at room and respectively physiological temperature). The ability of pHEMA to be loaded with indomethacin as model drug, and the release of the bioactive compound from the polymeric network, were also evaluated.
Experimental Part

Materials
2-Hydroxyethyl Methacrylate (HEMA) (from Fluka, purity >96%) was purified by passing through an inhibitor removal column. The tensioactive substance, sodium lauryl sulfate (SDS) (C 12 H 25 O 4 SNa), was purchased from Sigma-Aldrich. Poly(aspartic acid) (PAS) (M w = 15000) was synthesized in our laboratory as it was detailed in the reference [14] (hydrolysis of polysuccinimide). β-cyclodextrine (CD) (M w = 1135, purum, ≥99%), from Sigma-Aldrich, and poly(vinyl alcohol) (PVA), from Oriental Chemical Industry (M w = 120000 Da, hydrolysis degree = 88), were used without further purification. The radical initiator 4, 4'-azobis(cyanopentanoic acid) (ACPA) (from Fluka, 98%) was used also without further purification. The water used in all experiments was purified using an Ultra Clear TWF UV System.
Polymer Compounds Preparation
Polymerization Process
The radical polymerization processes were conducted under nitrogen atmosphere, in a temperature bath at 80˚C, with a mechanical stirring rate of 180 rpm. The polymerization formulations are presented in Table 1 .
After synthesis the polymeric particles were precipitated three times with methanol and finally freeze-dried by lyophilization for 24 h.
Polymer Matrices Loading with Indomethacin
In order to evaluate the capacity of the networks of the synthesized polymers to be loaded with drug, and to determine as well the release behavior, Indomethacin (INN), as a model drug, was loaded into the pHEMA PVA , pHEMA PAS , and respectively pHEMA CD polymeric ma- trices. The drug powder was dissolved in ethanol/phosphate buffer solution (pH = 7.2) to obtain a concentration of c = 1.9005 × 10 −5 mol/ml. Then the polymers were immersed in this solution and let to swell till equilibrium (the ratio INN/copolymer was about 1/10 wt%). The swollen drug-loaded samples were then dried at ambient temperature for several days until the prepared particles had constant mass. The particles were then freeze-dried to obtain the resultant drug-loaded network to use them in the release experiments.
Polymers and Polymer Composites Characterization
Polymers FTIR Spectra
Polymers FTIR spectra were recorded on a Vertex Brucker Spectrometer in an absorption mode ranging from 4000 cm −1 to 400 cm −1 (Figure 1 ). The polymeric samples were grounded with potassium bromide (KBr) powder and compressed into a disc to analysis. Spectra were acquired at 4 cm −1 resolution as an average of 64 scans. The registered spectra confirms pHEMA achievement small recorded differences being attributed on the used protective colloids. Thus, v (O-H) stretching vibration in HEMA is observed in the 3400 -3500 cm −1 range as broad absorptions, and the strong band at ~2950 cm −1 and ~2970 cm −1 is attributed to the v (C-H). Another strong band at ~1730 cm −1 is assigned to v (C=O) group, at ~2940 cm −1 to v (C-H) stretching of -CH 3 , and also at ~1270 cm −1 to v (C-O) stretching vibration.
Thermal Analysis
The thermal characterization of the polymers was performed on a Jupiter STA 449 F1 (Netzsch) simultaneous TGA/DSC device calibrated with high purity chemicals, respectively with standard indium, tin, zinc and aluminum. The samples were maintained in a controlled 
SEM Studies
were performed on samples fixed by means of colloidal copper supports. The samples were covered by sputtering with a thin layer of gold (EMITECH K 550×). The coated surface was examined by using an Environmental Scanning Electron Microscope (ESEM) type Quanta 200 operating at 30 kV with secondary electrons in high vacuum mode.
Swelling Studies
Dynamic swelling measurements were performed in buffer solutions at two pH values, 2.4 and 7.4, and each at two temperatures: 24˚C and respectively 37˚C. The amount of the adsorbed solution was monitored gravimetrically: the swollen particles were regularly extracted from the swelling medium, wetted on the surface, weighed and placed again in the same bath. The measurements were continued until the constant weight was reached for each studied sample. The degree of swelling (Q) was calculated as follows:
where M(t) is the weight of the swollen particles at time t and M 0 is the weight of the sample before swelling. All the swelling experiments were performed in triplicate.
Loading Evaluation
The evaluation of the drug distribution in the polymeric matrix was made using near infrared chemical imaging (NIR-CI) technique and the correspondingly statistical analysis. The original image data sets of samples were collected by a completely integrated Chemical Imaging Workstation from SPECIM Spectral Imaging Ltd (Finland). Acquisition of spectral lines was made on the wavelength range starting from 1100 nm to 2500 nm. Images with 320 × 640 pixels were recorded with a spectral camera (NIR model based on an ImSpector N17E imaging spectrograph). Data pre-processing, preliminary visualization and the proper characterization were performed using Evince program (UmBio, Sweden), a software package designed for visualization and analysis of hyper spectral image cubes. The contrast in the chemical images is compared by methods using the intensity of a single wavelength, the peak-height ratio of two wavelengths, the correlation coefficient with a reference spectrum and the principal 
Results and Discussions
Thermal Analysis
The evolution of the thermal decomposition of the polymers synthesised with different protective colloids is illustrated in Figure 2 . The registered differences are attributed to the influence of the protective colloids upon thermal characteristics of the polymers synthesised in their presence. For pHEMA CD two stages of decomposition were registered between 167˚C to 223˚C and respectively from 321˚C to 421˚C. The weight loss registered at the beginning of the decomposition process is attributed to the loss of the water of inclusion inside the cavity of CD, phenomena also reported by other authors [15] . The pHEMA PAS and pHEMA PVA samples have as well two stages of decomposition, but the first one is not as evident as in case of pHEMA CD samples. The specific parameters corresponding to the main decomposition step, the second one, of the studied samples are presented in Table 2 . These data confirm the influence of the protective colloid on the stability of the pHEMA.
The thermal stability of polymers can be ordered as follows: PHEMA CD < PHEMA PAS < PHEMA PVA . The differences registered in the thermal stability are considered to be in relation with surfactants structure, practically with the number of physical bonds, especially hydrogen bonds, performed between pHEMA and the tested protective colloids. In this context, the molecular mass of the protective colloids is as well an important factor in generating intermolecular interactions with the chains of the new synthesised polymer compound. Thus, the best thermal stability of the pHEMA PAV is in agreement with the PAV molecular weight of about 70,000, being followed by pHEMA PAS with M PAS ~15,000 and finally by pHEMA CD .
SEM Studies
Information concerning the morphology of the studied polymeric samples are obtained by SEM studies and are presented in Figures 3(a)-(c) . There are clear differences between the polymers morphology stabilized by PVA (Figure 3(a) ) or CD or PAS as protective colloid (Figures 2(b) and (c) ). Thus, an aspect rather porous presents pHEMA PVA , while pHEMA CD and pHEMA PAS exhibit a more uniform aspect as self-assembled honeycomb nanofibers (pHEMA PAS ) or lacing nanofibers (pHEMA CD ). Also, the pore size decreases from about 17 µm for PHEMA PVA to ~3 µm for PHEMA CD and ~2 µm for PHEMA PAS . The cause for the size modification of the network meshes was attributed to the molecular weights of the used protective colloids and to their specific intermolecular interactions with the pHEMA chains [6] .
The Swelling Behavior
It is well known the hydrophobic character of pHEMA. At the same time, when the polymer is subjected to water it swells due to the hydrophilic pendant groups. It is expected as the protective colloid type, used for the PHEMA synthesis, to influence as well the capacity of water absorption. The swelling kinetic of the polymeric particles related on the swelling conditions, respectively at two pH values (2.4 and 7.2) and correspondingly at two temperatures (24˚C and 37˚C), is illustrated in Figure 4 . The highest swelling capacity was recorded for pHEMA PAS sample, followed by PHEMA CD , while the lowest swelling behavior corresponds to PHEMA PVA variant, no matter the swelling conditions are ( Table 3 ). The swelling behavior of pHEMA PAS is justified by the superabsorbent and polyelectrolyte character of PAS, the intervened electrostatic forces contributing to the improvement of the polymer swelling capacity. Regarding the pHEMA PVA swelling behavior it is justified by the hydrogen bonds come along PAV and pHEMA polymer chains (Figure 5) into the detriment of bonds between pHEMA and solvent. The swelling behavior of pHEMA PVA is improved in acidic medium both at room temperature and at 37˚C. The most sensitive sample is pHEMA PAS , its behavior at swelling being slightly decreased with the increase of the temperature in acid and neutral medium. Thus, swelling is two times smaller at 37˚C comparing with the room temperature. At the same time, pHEMA CD is practically not sensitive either to pH or temperature, in the studied intervals.
In the context of the obtained results the higher swelling behaviour registered at the acidic pH was attributed to the decrease of the osmotic pressure. Between the carboxylic groups of PAS and the ionized groups of medium appear the repulsion forces which reduce the osmotic pressure allowing the solvent molecules to penetrate the network meshes and thus increasing the polymers swelling capacity.
coupling bioactive compounds and to control the drug release in biological medium [16] . Near-infrared chemical imaging (NIR-CI) was used as non-destructive method, to evaluate the distribution of indomethacin (INN) in the synthesized polymeric samples. The method represents a challenging combination for visualizing the spatial distribution and homogeneity of drug accompanied with chemometrics tools and image-processing method [17] . Evaluation of drug loading degree and indomethacin/polymeric system homogeneity was estimated by PLS-DA (Partial least squares-Discriminant Analysis). Figure 6 illustrates the score images derived from the indomethacin component class. In the score images, the pixels with higher and lower score values are indicated by light gray and dark code colors, respectively. For the polymeric network loaded with indomethacin, the code color in the most region of the score images is gray, the intermediate color between light gray (the cod color of the polymers) and dark gray colors (the code color of indomethacin). The predominantly gray score images evidences the homogeneity distribution of drug in the synthesized polymeric matrices. Also, the code color attests the qualitative differences between the polymeric networks variants loaded with drug. As it is well known the physicochemical properties of the polymeric network as well as the drug loading method determine the further release mechanism of the bioactive product [18] . The release profiles of INN from the polymeric loaded samples, in physiological buffer solution (pH = 7.4, and 37˚C) are presented in Figure 7 . For all polymer/INN complex formulations (Figure 8) , the sus-
In Vitro Controlled Release of Indomethacin
The Evaluation of the Drug Homogeneity into Polymeric Matrices
PAS, CD and PVA were used during pHEMA synthesis not only for their character as protective colloids but as well to improve the ability of the homopolymer for tained release behavior was observed. During the first 300 minutes, all samples present a faster release of INN (burst effect). The burst release is owing to the presence of the drug at the surface of the polymeric particles. After this interval of time the release kinetic is slowed, behavior which is attributed to the links intervened between drug and the protective colloid. Thus, pHEMA PAV samples present the slowest release rates, while the pHEMA CD and pHEMA PAS samples are releasing much faster the drug. This aspect is sustained as well by the largest pores of pHEMA PAV (Figure 3 ) which can keep and maintain the drug inside the network, and not only at surface as in case of pHEMA CD and pHEMA PAS samples. And more then that PHEMA PAV have the lowest swelling degree which may explain as well this slowest release. The entire quantity of loaded indomethacin was released from pHEMA PAS and pHEMA CD samples during the time of observation, while just 79% of drug was released from PHEMA PAV .
Conclusion
The study evidences the possibility of using poly(vinyl alcohol), β cyclodextrin or poly(aspartic acid) as protective colloids for the preparation of poly(2-hydroxyethyl methacrylate) through radical processes of polymerization. FTIR spectra confirm the synthesis of pHEMA as well as the presence of PVA, CD or PAS. The influence of the protective colloids was put into evidence by the different behaviors of the synthesized homopolymers during thermal decomposition. Thus, polymers can be ranked in the following order of their thermal stability: pHEMA PAV > pHEMA PAS > pHEMA CD , behaviour justified by the increased numbers of hydrogen bonds intervened between the molecular chains and related to the molecular weights of the protective colloids. The shape and morphology of the pHEMA structure were found to be the effective result of the used protective colloids. Therefore, complementary SEM observations evidenced the role played by the surfactants: the particles are changed from irregular aggregates in the case of using PVA, to well-defined filaments in the case of PAS, or tracery when CD is used. The swelling capacity is also depending on the protective colloids variant used during pHEMA synthesis. Thus, the swelling degree of the polymers is growing in the following order: pHEMA PAV < pHEMA CD < pHEMA PAS . The behavior was justified by the core/ shell structure of the PHEMA micelles with 1) the hydrophobic segment of PAV shell oriented on the exterior of the micelle surface, as well as 2) the superabsorber character of PAS and 3) hydrophilic nature of CD. The synthesized pHEMA particles were used as matrix for coupling indomethacin as model drug. The NIR-CI me-
